PROCEPT BioRobotics officer plans sale of 373 shares

Officer Barry L. Templin filed a Rule 144 notice to potentially sell 373 PRCT common shares related to vested equity compensation.

Rhea-AI Filing Summary

PROCEPT BioRobotics Corp (PRCT) has a planned sale of common stock reported for the account of officer Barry L. Templin under Rule 144. The notice covers the potential sale of 373 shares of common stock, with the shares originating from restricted stock vesting on September 8, 2026.

The shares are held at Fidelity Brokerage Services LLC, and the remarks state that the sale includes an amount needed to satisfy a tax obligation from the settlement of a vested equity award distribution. Fidelity signed as attorney-in-fact for Barry L. Templin.

Key Figures

Shares to be sold: 373 shares Aggregate value of shares: $7,815.54 Vesting date of restricted stock: September 8, 2026 +1 more

4 metrics

Shares to be sold 373 shares Common stock for the account of Barry L. Templin under Rule 144

Aggregate value of shares $7,815.54 Total value listed for the 373 common shares

Vesting date of restricted stock September 8, 2026 Acquisition date of the restricted stock being sold as compensation

Date of notice September 9, 2026 Date the Rule 144 notice was signed and dated

Key Terms

Rule 144, restricted stock vesting, vested equity award distribution, attorney-in-fact

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock vesting financial

"Common | 09/08/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

vested equity award distribution financial

"resulting from the settlement of a vested equity award distribution."

attorney-in-fact regulatory

"as attorney-in-fact for Barry L. Templin"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

What transaction involving PRCT shares is disclosed in this Form 144 notice?

The notice discloses a potential sale of 373 shares of PROCEPT BioRobotics Corp common stock for the account of officer Barry L. Templin under Rule 144, with the shares arising from a restricted stock vesting on September 8, 2026.

What is the approximate value of PRCT shares covered by this Rule 144 notice?

The notice lists an aggregate value of $7,815.54 for the 373 PRCT common shares referenced, based on the information provided in the securities section.

How did Barry L. Templin acquire the PRCT shares to be sold?

The 373 PRCT common shares to be sold were acquired through restricted stock vesting on September 8, 2026, with the nature of acquisition described as Compensation.

Why does the Form 144 notice mention taxes for PRCT shares?

The remarks explain that the planned sale of PRCT shares includes an amount necessary to cover a tax obligation arising from the settlement of a vested equity award distribution for Barry L. Templin.

Who is executing the potential PRCT share sale for Barry L. Templin?

The shares are held at Fidelity Brokerage Services LLC. The notice is signed by Gary Redman as a duly authorized representative of Fidelity, acting as attorney-in-fact for Barry L. Templin.

On which market are the PRCT shares in this Rule 144 notice listed?

The common stock referenced in the notice is listed on NASDAQ, as indicated in the securities information section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/09/2026 - 03:15 PM Accepted by SEC EDGAR 09/09/2026 - 03:14 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002132820
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PROCEPT BioRobotics Corp
SEC File Number	001-40797
Address of Issuer	150 BAYTECH DRIVE SAN JOSE CALIFORNIA 95134
Phone	6502329832
Name of Person for Whose Account the Securities are To Be Sold	Templin Barry L
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	373	7815.54	57273659	09/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/08/2026	Restricted Stock Vesting	Issuer			373	09/08/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	09/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gary Redman, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Barry L. Templin
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)